Patients’ self-reported adherence to capecitabine on XELOX treatment in metastatic colorectal cancer: findings from a retrospective cohort analysis-Reference-Cited by-同舟云学术

Patients’ self-reported adherence to capecitabine on XELOX treatment in metastatic colorectal cancer: findings from a retrospective cohort analysis

Published:2015-04 Issue: Volume: Page:561
ISSN:1177-889X
Container-title:Patient Preference and Adherence
language:en
Short-container-title:PPA

Author:

Kawakami Kazuyoshi,Yokokawa Takashi,Nakamoto Eri,Sugita Kazuo,Hagino Akane,Suenaga Mitsukuni,Mizunuma Nobuyuki,Oniyama Sayaka,Machida Yoshiaki,Yamaguchi Toshiharu,Hama Toshihiro,Mae Yutarou

Publisher

Informa UK Limited

Subject

Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Social Sciences (miscellaneous),Medicine (miscellaneous)

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prolonged administration of the granisetron transdermal delivery system reduces capecitabine plus oxaliplatin regimen induced nausea and vomiting;BMC Cancer;2024-07-18

2. Key aspects of medication adherence to oral anticancer drugs: A literature review;Meditsinskiy sovet = Medical Council;2024-01-17

3. Prolonged Administration of the Granisetron Transdermal Delivery System Reduces Capecitabine plus Oxaliplatin Regimen–Induced Nausea and Vomiting;2023-08-21

4. Study protocol for a prospective observational study to evaluate the efficacy of fosnetupitant for long-delayed chemotherapy-induced nausea and vomiting in patients receiving platinum- based chemotherapy (LODEC-N);2023-07-11

5. Patient Safety Management Practiced by Pharmacy Pharmacists Using Their Training at Oncology Hospital;YAKUGAKU ZASSHI;2023-03-01